CEO Hoyt Casey Increases Direct Ownership Following Equity Award Vesting
VMD sits 23% above its 52-week low of $5.93.
Summary
Hoyt Casey, CEO of Viemed Healthcare, increased his direct ownership by a net of 36,032 shares following the vesting of restricted stock units and phantom share units, with a gross acquisition value of $453,818.
Key Events · Ownership and Investor Activity · VMD
-
CEO Acquires Shares from Equity Awards
Hoyt Casey, CEO and Director, acquired 61,997 common shares through the vesting of restricted stock units and phantom share units, representing a gross value of $453,818.
-
Shares Disposed for Tax and Issuer
A total of 13,565 shares were withheld for tax obligations and 12,400 shares were disposed to the issuer, totaling $194,478 in dispositions related to the vesting.
-
Net Increase in Direct Holdings
Following these transactions, the CEO's direct ownership increased by a net of 36,032 shares, demonstrating an increased stake in the company.
Analysis · VMD · Industrial Applications And Services
This Form 4 filing reports that CEO Hoyt Casey acquired shares through the vesting of restricted stock units and phantom share units. While a portion of these shares were subsequently disposed of to cover tax obligations and through a disposition to the issuer, the gross value of shares acquired from these awards was $453,818. This event results in a net increase in the CEO's direct ownership, signaling continued commitment and confidence in Viemed Healthcare's performance.
How filings like this one have moved
In the 30 days to Oct 1, 2026, 30.2% of the 1644 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was -0.49%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, VMD was trading at $7.32 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $278.3M. The 52-week trading range was $5.93 to $8.62. This filing was assessed with positive market sentiment and an importance score of 7 out of 10.